Thermo Fisher Scientific, LIMS & Laboratory Software services

To support the manufacturing of Cell and Gene Therapies, we have developed innovative chromatography solutions, specifically designed to improve the downstream purification of mRNA and viral vectors such as the Adeno-Associated Virus (AAV), lentivirus, and Adv5.

Connecting your patients, your treatments - all in the comfort of their own home with an end-to-end solution. Today, accelerating clinical trials to gain speed to market without compromising trial quality is the most critical aspect of success. However, the traditional clinical trial model doesn’t account for the patient’s travel time to the clinical site, patient money needed for parking, or time off from work several times per month. Most patients want to be considered when the study is designed and are reluctant to sign up for trials that aren’t convenient to their location, their schedule, or their lifestyle. As a result, many clinical sites are under enrolling or have a high dropout rate that negatively impacts the study duration and costs, extending timelines and overspending on budgets.

The power of partnership to maximize laboratory productivity. It’s official: Based on performance tests, Ortho Clinical Diagnostics now recommends using Thermo Scientific MAS Quality Controls with their VITROS Analyzers. In an exclusive agreement, Ortho Clinical Diagnostics will promote and distribute Thermo Scientific MAS Quality Controls and LabLink xL Quality Assurance Software for VITROS Analyzers globally.

The Thermo Fisher Scientific Amplitude Solution is a new, high throughput, highly automated molecular testing solution that can analyze up to 8,000 COVID-19 specimens in 24 hours. The Amplitude Solution can help laboratories quickly scale COVID-19 testing to volumes needed to help reduce the spread of disease and restore economies and communities. This solution offers maximum throughput with minimal hands-on time, equipment, and staffing.

The Oncomine Clinical Research Grant Program supports investigator-initiated studies (IIS) and education projects, on molecular testing in oncology and reproductive health, with the goal to increase high quality molecular profiling for patients and to improve clinical outcomes in the future. Proposal reviews are conducted by independent and internationally recognized experts together with Thermo Fisher Scientific medical and scientific leadership. Funding is considered based on scientific merit and alignment with strategic areas of focus. The application process is managed by the Oncomine Clinical Research Grant Office part of the Medical Affairs team of the Clinical Sequencing Division at Thermo Fisher Scientific. For detailed information about how to apply, including documentation requirements, review process, and decision notification, refer to the document Guidelines for Applicants.